15
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Autoantibody Binding to Steroid 21-hydroxylase – Effect of Five Mutations

, , , , &
Pages 253-259 | Received 29 Nov 1996, Published online: 07 Jul 2009

References

  • Bottazzo G. F., Mirakian R., Drexhage M. A. Adrenalitis, oophoritis and autoimmune polyglandular disease. Clinical Immunology Principles and Practice, RR. Rich. Mosby-Year Book, Inc. 1996; 1523–1536
  • Rees Smith B., Furmaniak J. Adrenal and gonadal autoimmune diseases. J. Clin. Endocrinol. Metab. 1996; 80(5)1502–1505
  • Chen S., Sawicka J., Betterle C, Powell M, Prentice L., Volpato M. etal. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease and premature ovarian failure. J. Clin. Endocrinol. Metab. 1996; 81(5)1871–1876
  • Wedlock N., Asawa T., Baumann-Antczak A., Rees Smith B., Furmaniak J. Autoimmune Addison's disease: Analysis of autoantibody binding sites on human steroid 21-hydroxylase. FEBS. Letts. 1993; 332: 123–126
  • Asawa T., Wedlock N., Baumann-Antczak A., Rees Smith B., Furmaniak J. Naturally occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody binding. J. Endocrinol. Metab. 1994; 79: 372–376
  • Furmaniak J., Kominami S., Asawa T., Wedlock N., Colls J., Rees Smith B. Autoimmune Addison's disease –evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency. J. Clin. Endocrinol. Metab. 1994; 79: 1517–1521
  • Boscaro M, Betterle C, Volpato M., Fallo F., Furmaniak J., Rees Smith B., Sonino N. Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. J. Clin. Endocrinol. Metab. 1996; 81(8)2801–2804
  • Miller W. L. Clinical Review 54: Genetics, diagnosis and management of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 1994; 78(2)241–246
  • Wilson R. C, Mercado A. B., Cheng K. C., New M. E. Steroid 21-hydroxylase deficiency: Genotype may not predict phenotype. J. Clin Endocrinol Metab. 1995; 80(8)2322–2329
  • Azziz R., Dewailly D., Owerbach D. Clinical review 56. Nonclassic adrenal hyperplasia: current concepts. J. Clin. Endocrinol. Metab. 1994; 78(4)810–815
  • White P. C, New M. I., Dupont B. Structure of human steroid 21-hydroxylase genes. Proc. Natl. Acad. Sci. USA. 1986; 83: 5111–5115
  • Bednarek J., Furmaniak J., Wedlock N., Kiso Y., Baumann-Antczak A., Fowler S. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS. Letts. 1992; 309: 51–55
  • Hsu L-D., Hsu N-C, Guzova J. A., Guzov V., Chang S-F., Chung B-C. The common I172N mutation causes conformational change of cytochrome P450c21 revealed by systematic mutation, kinetic and structural studies. J. Biol. Chem. 1996; 271(6)3306–3310
  • Hu M-C, Hsu L-C., Chung B-C. Function and membrane topology of wild-type and mutated cytochrome p-450c21. Biochem. J. 1996; 316: 325–329
  • Colls J., Betterle C, Volpato M., Prentice L., Rees Smith B., Furmaniak J. Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases. Clin. Chem. 1995; 41: 367–374
  • Laemmli J. K. Cleavage of structural proteins during the assembly of the head of bacteriophage. T4. Nature 1970; 227: 680–684
  • Birk H. W., Koepsell H. Reaction of monoclonal antibodies with plasma membrane proteins after binding on nitrocellulose: renaturation of antigenic sites and reduction of non-specific antibody binding. Anal. Biochem. 1987; 164: 12–22
  • Gonzalez F. J. The molecular biology of cytochrome p450s. Pharmacological reviews 1989; 40(4)243–276
  • Picado-Leonard J., Miller W. L. Cloning and sequence of the human gene for P450cl7 (steroid 17a-hydroxylase/17: 20 Lyase): similarity with the gene for P450c21. DNA 1987; 6(5)439–448
  • Lin D., Zhang L-H., Chiao E., Miller W. L. Modeling and mutagenesis of the active site of human p450cl7. Mol. Endocrinol 1994; 8: 392–402
  • Richter W., Northemann W., Müller M., Böhm B. O. Mapping of an autoreactive epitope within glu-tamate decarboxylase using a diabetes-associated human monoclonal autoantibody and an epitope cDNA library. Hybridoma 1996; 15(2)103–108
  • Bermann M., Magee M., Koenig R. J., Kaplan M. M., Arscott P., Maastricht J. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab. 1993; 77(4)1098–1101
  • Baker J. R., Arscott P., Johnson J. An analysis of the structure and antigenicity of different forms of human thyroid peroxidase. Thyroid 1994; 4(2)173–178
  • Arscott P. L., Koenig R. J., Kaplan M. M., Glick G. D., Baker J. R. Unique autoantibody epitopes in an immunodominant region of thyroid peroxidase. J. Biol. Chem. 1996; 271(9)4966–4973

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.